{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T03:21:15Z","timestamp":1776396075896,"version":"3.51.2"},"reference-count":57,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"unspecified","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2023,10,31]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Optimal pharmacological treatment of tuberculosis (TB) requires a multidisciplinary team, yet the hospital pharmacist\u2019s role is unclear. We aimed to analyse hospital pharmacist-provided clinical pharmacy services (CPS) implementation in TB care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>A nationwide survey-based online cross-sectional study was conducted on hospital pharmacists in Indonesia from 1 November 2022 to 22 November 2022. Outcomes were the extent of pharmacists\u2019 involvement in multidisciplinary TB care, TB-related CPS provided and views on TB-related CPS. The probability of pharmacists\u2019 involvement in multidisciplinary TB teams was assessed using logistic regression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 439 pharmacists (mean age 31.2\u00b16.22 years, 78% female) completed the survey. Thirty-six per cent were part of multidisciplinary TB care, and 23% had TB-related tasks. Adherence monitoring (90%) and drug use evaluation (86%) were the most conducted TB-related CPS. Pharmacists\u2019 views on TB-related CPS implementation were generally positive, except for financial incentives. Work experience (OR 1.99, 95% CI 1.09 to 3.61), ever received TB-related training (OR 3.51, 95% CI 2.03 to 6.14) and specific assignments to provide TB-related CPS (OR 8.42, 95% CI 4.99 to 14.59) significantly increased pharmacist involvement in multidisciplinary TB care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Around one-third of hospital pharmacists are part of multidisciplinary TB care, with medication adherence and drug use monitoring as primary tasks. Pharmacists\u2019 experience, training, assignment to provide TB-related CPS and financial incentives are key elements for further implementation in multidisciplinary TB care. Pharmacists should proactively support current TB care and conduct operational research, sharing data with healthcare peers and fostering a collaborative multidisciplinary TB care team.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjresp-2023-001887","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T12:08:33Z","timestamp":1699618113000},"page":"e001887","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Multidisciplinary tuberculosis care: leveraging the role of hospital pharmacists"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8909-4589","authenticated-orcid":false,"given":"Deni","family":"Iskandar","sequence":"first","affiliation":[{"name":"Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center, Groningen, The Netherlands"},{"name":"Faculty of Pharmacy, Bhakti Kencana University, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan S","family":"Pradipta","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran University, Bandung, Indonesia"},{"name":"Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Bandung, Indonesia"},{"name":"Indonesian Tuberculosis Research Network\/JetSet TB, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ani","family":"Anggriani","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Bhakti Kencana University, Bandung, Indonesia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten J","family":"Postma","sequence":"additional","affiliation":[{"name":"Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center, Groningen, The Netherlands"},{"name":"Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Bandung, Indonesia"},{"name":"Research Institute Science in Healthy Aging and healthcaRE (SHARE), University of Groningen, University Medical Center, Groningen, The Netherlands"},{"name":"Department of Economics, Econometrics & Finance, Faculty of Economic & Business, University of Groningen, Groningen, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Job F M","family":"van Boven","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy & Pharmacology, University of Groningen, University Medical Center, Groningen, The Netherlands"},{"name":"Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center, Groningen, The Netherlands"},{"name":"Center for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,10]]},"reference":[{"key":"2025083110260608000_10.1.e001887.1","unstructured":"World Health Organization . Global tuberculosis report 2022. Geneva World Health Organization; 2022. Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2022"},{"key":"2025083110260608000_10.1.e001887.2","unstructured":"World Health Organization . Implementing the end TB strategy: the essentials. Geneva World Health Organization; 2022. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240065093"},{"key":"2025083110260608000_10.1.e001887.3","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/S2214-109X(22)00455-7","article-title":"Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: national trends 2017-19","volume":"11","author":"Iskandar","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025083110260608000_10.1.e001887.4","unstructured":"Whittlesea C , Hodson K . Clinical pharmacy and therapeutics. United Kingdom: Elsevier, 2019."},{"key":"2025083110260608000_10.1.e001887.5","first-page":"1","article-title":"The impact of first-line anti-tubercular drugs' pharmacokinetics on treatment outcome: a systematic review","volume":"13","author":"Sileshi","year":"2021","journal-title":"Clin Pharmacol"},{"key":"2025083110260608000_10.1.e001887.6","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.5588\/ijtld.18.0779","article-title":"Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French consilium","volume":"23","author":"Guglielmetti","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110260608000_10.1.e001887.7","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.17.0608"},{"key":"2025083110260608000_10.1.e001887.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-12005-y","article-title":"Barriers and strategies to successful tuberculosis treatment in a high-burden tuberculosis setting: a qualitative study from the patient\u2019s perspective","volume":"21","author":"Pradipta","year":"2021","journal-title":"BMC Public Health"},{"key":"2025083110260608000_10.1.e001887.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.10.016"},{"key":"2025083110260608000_10.1.e001887.10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00228-020-02846-8","article-title":"Facilitators and barriers for performing comprehensive medication reviews and follow-up by multiprofessional teams in older hospitalised patients","volume":"76","author":"Kempen","year":"2020","journal-title":"Eur J Clin Pharmacol"},{"key":"2025083110260608000_10.1.e001887.11","doi-asserted-by":"publisher","DOI":"10.1177\/1049732314523680"},{"key":"2025083110260608000_10.1.e001887.12","unstructured":"Ministry of Health . National guidelines for medical services tuberculosis management [Jakarta]. 2020. Available: https:\/\/tbindonesia.or.id\/pustaka\/pedoman\/umum\/pedoman-nasional-pelayanan-kedokteran-tata-laksana-tuberkulosis\/ [Accessed 12 Aug 2021]."},{"key":"2025083110260608000_10.1.e001887.13","unstructured":"The President of The Republic of Indonesia . Ordinance of the president of the Republic of Indonesia No.67 regarding tuberculosis control. 2021. Available: https:\/\/peraturan.bpk.go.id\/Home\/Details\/174557\/perpres-no-67-tahun-2021"},{"key":"2025083110260608000_10.1.e001887.14","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of web surveys: the checklist for reporting results of Internet E-surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J Med Internet Res"},{"key":"2025083110260608000_10.1.e001887.15","unstructured":"Yamane T . Statistics an introductory analysis, 3rd edn. New York, NY: Harper & Row, 1973."},{"key":"2025083110260608000_10.1.e001887.16","unstructured":"Mahendradhata Y , Trisnantoro L , Listyadewi S , et al . Health systems in transition: The Republic of Indonesia Health System Review. New Delhi, India: World Health Organization, 2017."},{"key":"2025083110260608000_10.1.e001887.17","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-4-50"},{"key":"2025083110260608000_10.1.e001887.18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.sapharm.2019.06.018","article-title":"Factors influencing the implementation of clinical pharmacy services for hospitalized patients: a mixed-methods systematic review","volume":"16","author":"Onozato","year":"2020","journal-title":"Res Social Adm Pharm"},{"key":"2025083110260608000_10.1.e001887.19","unstructured":"CFIR Research Team-Center for Clinical Management Research . Updated CFIR Constructs 2022. Available: https:\/\/cfirguide.org\/wp-content\/uploads\/2022\/11\/CFIR-Updated-Comprehensive-Matrix-Blue.xlsx [Accessed 27 May 2023]."},{"key":"2025083110260608000_10.1.e001887.20","doi-asserted-by":"crossref","unstructured":"Holden RR . Face validity. In: Weiner IB , Craighead WE , eds. The Corsini Encyclopedia of Psychology. Berlin\/Heidelberg: Wiley, 2010: 1\u20132.","DOI":"10.1002\/9780470479216.corpsy0341"},{"key":"2025083110260608000_10.1.e001887.21","unstructured":"Cohen RJ , Swerdlik ME . Psychological testing and assessment: an introduction to tests and measurement, 7th edn. Boston: McGraw-Hill Higher Education, 2010."},{"key":"2025083110260608000_10.1.e001887.22","unstructured":"Fathelrahman AI , Ibrahim MIM , Wertheimer AI . Pharmacy practice in developing countries: Achievements and challenges. Amsterdam: Elsevier\/AP Academic Press is an imprint of Elsevier, 2016."},{"key":"2025083110260608000_10.1.e001887.23","doi-asserted-by":"crossref","DOI":"10.1186\/s12960-022-00767-4","article-title":"A national analysis of the pharmacy workforce in Indonesia","volume":"20","author":"Meilianti","year":"2022","journal-title":"Hum Resour Health"},{"key":"2025083110260608000_10.1.e001887.24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jinf.2018.10.004","article-title":"Risk factors of multidrug-resistant tuberculosis: a global systematic review and meta-analysis","volume":"77","author":"Pradipta","year":"2018","journal-title":"J Infect"},{"key":"2025083110260608000_10.1.e001887.25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-80560-2","article-title":"Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions","volume":"11","author":"Garin","year":"2021","journal-title":"Sci Rep"},{"key":"2025083110260608000_10.1.e001887.26","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192114552","article-title":"Implementation and effectiveness of a pharmacotherapeutic follow-up service for people with tuberculosis in primary healthcare","volume":"19","author":"Lara-J\u00fanior","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"2025083110260608000_10.1.e001887.27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.sapharm.2022.09.001","article-title":"Community pharmacists-led interventions in tuberculosis care: a systematic review","volume":"19","author":"Wong","year":"2023","journal-title":"Res Social Adm Pharm"},{"key":"2025083110260608000_10.1.e001887.28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1186905","article-title":"Clinical pharmacy services for tuberculosis management: a systematic review: a systematic review","volume":"14","author":"Iskandar","year":"2023","journal-title":"Front Pharmacol"},{"key":"2025083110260608000_10.1.e001887.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001357","article-title":"A scoping review of patient-centred tuberculosis care interventions: gaps and opportunities","volume":"3","author":"Myburgh","year":"2023","journal-title":"PLOS Glob Public Health"},{"key":"2025083110260608000_10.1.e001887.30","doi-asserted-by":"crossref","first-page":"100118","DOI":"10.1016\/j.jctube.2019.100118","article-title":"The high-quality health system 'revolution': re-imagining tuberculosis infection prevention and control","volume":"17","author":"van der Westhuizen","year":"2019","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"2025083110260608000_10.1.e001887.31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/PPA.S391930","article-title":"Social support, quality of care, and patient adherence to tuberculosis treatment in Peru: the mediating role of nurse health education","volume":"17","author":"Dilas","year":"2023","journal-title":"Patient Prefer Adherence"},{"key":"2025083110260608000_10.1.e001887.32","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-020-05354-3","article-title":"The effects of family, society and national policy support on treatment adherence among newly diagnosed tuberculosis patients: a cross-sectional study","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2025083110260608000_10.1.e001887.33","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5588\/ijtld.18.0490","article-title":"Why every word counts: towards Patient- and people-centered tuberculosis care","volume":"23","author":"Jaramillo","year":"2019","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110260608000_10.1.e001887.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253588","article-title":"Pharmacist-led educational interventions provided to healthcare providers to reduce medication errors: a systematic review and meta-analysis","volume":"16","author":"Jaam","year":"2021","journal-title":"PLoS One"},{"key":"2025083110260608000_10.1.e001887.35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.965806","article-title":"Perceptions of healthcare professionals and patients on the role of the pharmacist in TB management in Pakistan: a qualitative study","volume":"13","author":"Atif","year":"2022","journal-title":"Front Pharmacol"},{"key":"2025083110260608000_10.1.e001887.36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1331\/JAPhA.2014.13104","article-title":"Facilitating collaboration between pharmacists and physicians using an Iterative interview process","volume":"54","author":"Chui","year":"2014","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2025083110260608000_10.1.e001887.37","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.sapharm.2018.10.006","article-title":"Effectiveness and cost effectiveness of pharmacist input at the ward level: a systematic review and meta-analysis","volume":"15","author":"Dawoud","year":"2019","journal-title":"Res Social Adm Pharm"},{"key":"2025083110260608000_10.1.e001887.38","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-020-01096-z"},{"key":"2025083110260608000_10.1.e001887.39","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-018-3036-7","article-title":"Perceptions of a group of hospital pharmacists and other professionals of the implementation of clinical pharmacy at a high complexity public hospital in Brazil","volume":"18","author":"Alc\u00e2ntara","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2025083110260608000_10.1.e001887.40","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp160628"},{"key":"2025083110260608000_10.1.e001887.41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206115","article-title":"Perceived barriers to the implementation of clinical pharmacy services in a metropolis in northeast Brazil","volume":"13","author":"Santos J\u00fanior","year":"2018","journal-title":"PLoS One"},{"key":"2025083110260608000_10.1.e001887.42","doi-asserted-by":"crossref","first-page":"811","DOI":"10.5588\/ijtld.19.0754","article-title":"Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review","volume":"24","author":"Chimeh","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110260608000_10.1.e001887.43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S2213-2600(20)30047-3","article-title":"Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis","volume":"8","author":"Lan","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025083110260608000_10.1.e001887.44","doi-asserted-by":"crossref","DOI":"10.2196\/33062","article-title":"Digital health technologies to improve medication adherence and treatment outcomes in patients with tuberculosis: systematic review of randomized controlled trials","volume":"24","author":"Ridho","year":"2022","journal-title":"J Med Internet Res"},{"key":"2025083110260608000_10.1.e001887.45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5588\/ijtld.21.0373","article-title":"A randomised controlled trial to evaluate a medication monitoring system for TB treatment","volume":"26","author":"Acosta","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110260608000_10.1.e001887.46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01690-2022","article-title":"Combining digital adherence technology and therapeutic drug monitoring for personalised TB care","volume":"60","author":"Ghimire","year":"2022","journal-title":"Eur Respir J"},{"key":"2025083110260608000_10.1.e001887.47","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-020-0179-x","article-title":"Interventions to improve medication adherence in tuberculosis patients: a systematic review of randomized controlled studies","volume":"30","author":"Pradipta","year":"2020","journal-title":"NPJ Prim Care Respir Med"},{"key":"2025083110260608000_10.1.e001887.48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.5588\/ijtld.22.0188","article-title":"Clinical standards for the dosing and management of TB drugs","volume":"26","author":"Alffenaar","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083110260608000_10.1.e001887.49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/ajhp\/zxaa393","article-title":"ASHP guidelines on medication-use evaluation","volume":"78","author":"Afanasjeva","year":"2021","journal-title":"Am J Health Syst Pharm"},{"key":"2025083110260608000_10.1.e001887.50","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jpp\/rgac004","article-title":"Efficacy and safety of daily treatments for drug-susceptible pulmonary tuberculosis: a systematic review and network meta-analysis","volume":"74","author":"Imazu","year":"2022","journal-title":"J Pharm Pharmacol"},{"key":"2025083110260608000_10.1.e001887.51","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-07097-6","article-title":"The impact of hospital accreditation on the quality of healthcare: a systematic literature review","volume":"21","author":"Hussein","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"2025083110260608000_10.1.e001887.52","article-title":"An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional Behaviours and patient outcomes","volume":"2011","author":"Flodgren","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2025083110260608000_10.1.e001887.53","unstructured":"Ministry of Health . Pharmaceutical service standard in hospital(72). 2016."},{"key":"2025083110260608000_10.1.e001887.54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.46542\/pe.2022.222.225229","article-title":"An exploratory study of pharmacists' views on the development of a professional recognition system in Indonesia","volume":"22","author":"Meilianti","year":"2022","journal-title":"Pharm Educ"},{"key":"2025083110260608000_10.1.e001887.55","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.japh.2018.07.002","article-title":"Remunerated patient care services and injections by pharmacists: an international update","volume":"59","author":"Houle","year":"2019","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2025083110260608000_10.1.e001887.56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jctube.2019.100112","article-title":"Measuring and improving the quality of tuberculosis care: a framework and implications from the lancet global health commission","volume":"16","author":"Arsenault","year":"2019","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"2025083110260608000_10.1.e001887.57","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.8353","article-title":"Paper- or web-based questionnaire invitations as a method for data collection: cross-sectional comparative study of differences in response rate, completeness of data, and financial cost","volume":"20","author":"Ebert","year":"2018","journal-title":"J Med Internet Res"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2023-001887","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T17:26:20Z","timestamp":1756661180000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2023-001887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,11,10]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjresp-2023-001887"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2023-001887","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}